Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,503 shares of Class A Common Stock at a price of $15.65 per share on April 1, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On April 1, 2024, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), sold 2,503 shares of Class A Common Stock.
• The sale was executed at a price of $15.65 per share.
• Following the transaction, Boughton directly owns 166,866 shares of Hims & Hers Health, Inc.
• The sale was conducted under a Rule 10b5-1 trading plan adopted by Boughton on September 8, 2023.

Sentiment

Score: 5

Explanation: The document is a routine SEC Form 4 filing, indicating a stock sale by an officer under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

Sales by corporate insiders are a common occurrence and are often pre-planned through Rule 10b5-1 trading plans to avoid accusations of insider trading. Investors often monitor these transactions for signals about management's confidence in the company's future prospects.

Stakeholder Impact

• The sale of shares by a company officer could be perceived negatively by some shareholders, potentially leading to slight downward pressure on the stock price in the short term.

Key Dates